Acute Coronary Syndromes (ACS) in patients presenting without persistent ST-segment elevation (Management of)
The present document deals with the management of patients with suspected NSTE-ACS, replacing the document first published in 2000 and updated in 2002 and 2007. It includes all scientific evidence fully published as peer-reviewed papers, before May 2011.
Guidelines er godkendt af DCS 12/1 2012. Hvor der er kommentarer, afvigende dansk tradition samt forslag til forbedringer, er bemærkningerne knyttet til et nummer og en sidehenvisning. Dette nummer genfindes på relevant plads i den engelsksprogede udgave af guidelines.
Dyslipidaemias (Management of)
These Joint ESC/European Atherosclerosis Society (EAS) guidelines on the management of dyslipidaemias are complementary to the guidelines on CVD prevention in clinical practice and address not only physicians [e.g. general practitioners (GPs) and cardiologists] interested in CVD prevention, but also specialists from lipid clinics or metabolic units who are dealing with dyslipidaemias that are more difficult to classify and treat.
Guidelines er godkendt af DCS 12/1 2012. Hvor der er kommentarer, afvigende dansk tradition samt forslag til forbedringer, er bemærkningerne knyttet til et nummer og en sidehenvisning. Dette nummer genfindes på relevant plads i den engelsksprogede udgave af guidelines.
Hent godkendte guidelines inkl. danske kommentarer (6.67 MB)
Cardiovascular Diseases during Pregnancy (Management of) 2011
At present, 0.2–4% of all pregnancies in western industrialized countries are complicated by cardiovascular diseases (CVD) and the number of the patients who develop cardiac problems during pregnancy is increasing. Nevertheless, the number of such patients presenting to the individual physician is small. However, knowledge of the risks associated with CVD during pregnancy and their management are of pivotal importance for advising patients before pregnancy. Therefore, guidelines on disease management in pregnancy are of great relevance.
Guidelines er godkendt af DCS 12/1 2012. Hvor der er kommentarer, afvigende dansk tradition samt forslag til forbedringer, er bemærkningerne knyttet til et nummer og en sidehenvisning. Dette nummer genfindes på relevant plads i den engelsksprogede udgave af guidelines.
Hent godkendte guidelines inkl. danske kommentarer (1.56 MB)
Hent resume, smartphone-version, powerpoint slides mm. hos ESC
Device Therapy in Heart Failure (Focused Update) 2010
An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy.
Guidelines er godkendt af DCS 13/1 2011. Hvor der er kommentarer, afvigende dansk tradition samt forslag til forbedringer, er bemærkningerne knyttet til et nummer og en sidehenvisning. Dette nummer genfindes på relevant plads i den engelsksprogede udgave af guidelines.
Hent godkendte guidelines inkl. danske kommentarer (790.5 kB)
Myocardial Revascularisation (ESC Guideline for) 2010
Myocardial revascularization has been an established mainstay in the treatment of CAD for almost half a century. Coronary artery bypass grafting (CABG), used in clinical practice since the 1960s, is arguably the most intensively studied surgical procedure ever undertaken, while percutaneous coronary intervention (PCI), used for over three decades, has been subjected to more randomized clinical trials (RCTs) than any other interventional procedure. Recognizing the importance of the interaction between (interventional) cardiologists and cardiac surgeons, the leadership of both the ESC and EACTS has given this Joint Task Force, their respective Guideline Committee, and the reviewers of this document the mission to draft balanced, patient-centred, evidencedriven practice guidelines on myocardial revascularization.
Guidelines er godkendt af DCS 13/1 2011. Hvor der er kommentarer, afvigende dansk tradition samt forslag til forbedringer, er bemærkningerne knyttet til et nummer og en sidehenvisning. Dette nummer genfindes på relevant plads i den engelsksprogede udgave af guidelines.
Hent godkendte guidelines inkl. danske kommentarer (2.83 MB)
Atrial Fibrillation (Management of) 2010
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, occurring in 1–2% of the general population. Over 6 million Europeans suffer from this arrhythmia, and its prevalence is estimated to at least double in the next 50 years as the population ages. It is now 4 years since the last AF guideline was published, and a new version is now needed. AF confers a 5-fold risk of stroke, and one in five of all strokes is attributed to this arrhythmia. Ischaemic strokes in association with AF are often fatal, and those patients who survive are left more disabled by their stroke and more likely to suffer a recurrence than patients with other causes of stroke. In consequence, the risk of death from AF-related stroke is doubled and the cost of care is increased 1.5-fold. There has been much research into stroke prevention, which has influenced this guideline.
Guidelines er godkendt af DCS 13/1 2011. Hvor der er kommentarer, afvigende dansk tradition samt forslag til forbedringer, er bemærkningerne knyttet til et nummer og en sidehenvisning. Dette nummer genfindes på relevant plads i den engelsksprogede udgave af guidelines.
Hent godkendte guidelines inkl. danske kommentarer (3.1 MB)
Hent resume, smartphone-version, powerpoint slides mm. hos ESC
Grown-Up Congenital Heart Disease (Management of) 2010
Precise data on the size and composition of the GUCH population are still lacking and can be assumed to change constantly. The remarkable improvement in survival of patients with CHD has led to a continuously growing number of GUCH patients, in particular those with more complex disease. The present document refers to the previous ESC guidelines where recommendations for the transition from paediatric to adult care, the infrastucture and network of specialist GUCH centres with models of delivery, the actual delivery of patient care, and the requirements for training are covered in more detail. The previous guidelines stratified patient care into three levels: (i) patients who require care exclusively in the specialist centre; (ii) patients in whom shared care can be established with the appropriate general adult cardiac services; and (iii) patients who can be managed in ‘nonspecialist’ clinics (with access to specialized care if required). The current document in general did not attempt to assign a certain level of care just by diagnosis.
Guidelines er godkendt af DCS 13/1 2011. Hvor der er kommentarer, afvigende dansk tradition samt forslag til forbedringer, er bemærkningerne knyttet til et nummer og en sidehenvisning. Dette nummer genfindes på relevant plads i den engelsksprogede udgave af guidelines.
Hent godkendte guidelines inkl. danske kommentarer (2.26 MB)
Pre-operative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-Cardiac Surgery
”Pre-operative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-Cardiac Surgery” er fremlagt godkendelse af DCS på Efterårsmødet 28/10 2010. Godkendelsen repræsenterer DCSs officielle holdning på dette område.
Hent godkendte guidelines (1.54 MB)
Hent resume, smartphone-version, powerpoint slides mm. hos ESC
Guidelines for the diagnosis and management of syncope (version 2009)
The first ESC Guidelines for the management of syncope, were published in 2001, and reviewed in 2004.1 In March 2008, the CPG considered that there were enough new data to justify production of new guidelines.
The most relevant changes are listed here:
† An update of the classification of syncope in the larger framework of transient loss of consciousness (T-LOC).
† New data on epidemiology.
† A new diagnostic approach focusing on risk stratification of sudden cardiac death (SCD) and cardiovascular events after initial evaluation, including some recommendations for treatment in patients with unexplained syncope at high risk.
† Emphasis on the increasing role of a diagnostic strategy based on prolonged monitoring in contrast to the conventional strategy based on laboratory testing.
† An update of evidence-based therapy.
Rapporten er fremlagt til diskussion på DCS årsmøde 2010.
Hent de godkendte ESC guidelines (2.51 MB)
Hent resume, smartphone-version, powerpoint slides mm. hos ESC
Ændringer i kliniske retningslinjer for forebyggelse af CVD fra 2003 til 2007
I september 2007 udkom den 4. reviderede udgave af de europæiske anbefalinger for forebyggelse af kardiovaskulær sygdom (CVD).
Målet med de europæiske retningslinjer er, at de implementeres nationalt tillempet de enkelte landes muligheder. Styrken er at retningslinjerne er opnået på basis af en bred tværfaglig arbejdsgruppe forankret i europæiske/internationale selskaber med særligt fokus på at involvere de faggrupper, der foretager forebyggelsessamtaler og initierer livsstilsændringer, – sygeplejersker og praktiserende læger. Den tværfaglige danske arbejdsgruppe er nedsat på initiativ af Dansk Cardiologisk Selskab.
Den danske arbejdsgruppe har denne gang valgt kun at fokusere på de væsentligste ændringer og tilpasset disse ændringer til danske forhold.
Lia E. Bang, Gudrun Boysen, Bo Christensen, Hanne K. Rasmusen (formand), Ole Snorgaard og Henrik Sillesen
Rapporten er fremlagt til diskussion på DCS Efterårsmøde 2008.
Hent de godkendte ESC guidelines (6.85 MB)
Hent resume, smartphone-version, powerpoint slides mm. hos ESC